Envision Healthcare Receives a Hold from Cantor Fitzgerald


In a report released yesterday, Joseph France from Cantor Fitzgerald assigned a Hold rating to Envision Healthcare (NYSE: EVHC), with a price target of $40. The company’s shares closed on Friday at $42.

France observed:

“We rate EVHC 12-month price target of $40. The stock has been weak this year on concerns about the ER business as a proxy for hospital volumes, which have been weak, and uncertainty about its transition to in-network. EVHC is undertaking a strategic review of its business to boost shareholder value, but this process will likely take a while and its outcome is uncertain. Valuation Summary We arrive at our $40 price target using a blend of our DCF and comparable- company analysis.”

According to TipRanks.com, France is a 4-star analyst with an average return of 10.1% and a 56.0% success rate. France covers the Services sector, focusing on stocks such as Cross Country Healthcare, Five Star Quality Care, and US Physical Therapy.

Envision Healthcare has an analyst consensus of Moderate Buy, with a price target consensus of $45.55.

See today’s analyst top recommended stocks >>

Envision Healthcare’s market cap is currently $5.09B and has a P/E ratio of 45.36. The company has a Price to Book ratio of 0.79.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Envision Healthcare Corp. specializes in healthcare services. It provides a range of services including physician-led services, ambulatory surgery services, postacute care and medical transportation. It operates through the following segments: Physician Services, Medical Transportation, and Ambulatory Services.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts